Chronic refractory dyspnoea--evidence based management.

Publication Type:
Journal Article
Citation:
Australian family physician, 2013, 42 (3), pp. 137 - 140
Issue Date:
2013-03
Full metadata record
Files in This Item:
Filename Description Size
AFP2013V042N03_137.pdfPublished Version85.93 kB
Adobe PDF
BACKGROUND: Chronic refractory dyspnoea is defined as breathlessness daily for 3 months at rest or on minimal exertion where contributing causes have been treated maximally. Prevalent aetiologies include chronic obstructive pulmonary disease, heart failure, advanced cancer and interstitial lung diseases. OBJECTIVE: To distil from the peer reviewed literature (literature search and guidelines) evidence that can guide the safe, symptomatic management of chronic refractory dyspnoea. DISCUSSION: Dyspnoea is mostly multifactorial. Each reversible cause should be managed (Level 4 evidence). Non-pharmacological interventions include walking aids, breathing training and, in chronic obstructive pulmonary disease, pulmonary rehabilitation (Level 1 evidence). Regular, low dose, sustained release oral morphine (Level 1 evidence) titrated to effect (with regular aperients) is effective and safe. Oxygen therapy for patients who are not hypoxaemic is no more effective than medical air. If a therapeutic trial is indicated, any symptomatic benefit is likely within the first 72 hours.
Please use this identifier to cite or link to this item: